Introduction
maintained constant by addition of pcDEF 3 .
HEK293 cells were maintained at 37 °C in a humidified 5 % CO 2 /95 % air atmosphere in DMEM containing 2 mM L-glutamine, supplemented with 10 % (v/v) newborn calf serum. Cells were grown to 60-80 % confluency before transient tranfection in 100 mm dishes. Transfection was performed using LipofectAMINE reagent, according to the manufacturer's instructions.
Histamine H 1 -receptor binding studies
Cells used for radioligand binding-studies were harvested 48 h after transfection and homogenised in ice-cold H 1 R binding buffer (50 mM Na 2 /K-phosphate buffer (pH 7.4)).
For saturation isotherms cell membrane homogenates were incubated for 30 minutes at 30 °C with 0.01 to 17.0 nM [ or 100 µL buffer, respectively. The non-specific binding was determined in the presence of 1 µM mianserin for both radioligands. The incubations were stopped by rapid dilution with 3 mL ice-cold H 1 R binding buffer. The bound radioactivity was separated by filtration through Whatman GF/C filters that had been treated with 0.3% polyethyleneimine. Filters were washed twice with 3mL buffer and radioactivity retained on the filters was measured by liquid scintillation counting. Binding data were evaluated by a non-linear, least squares curve-fitting procedure using Graphpad Prism ® (GraphPad Software Inc., San Diego, CA). Protein concentrations were determined according to Bradford (Bradford, 1976) , using BSA as a standard. All data are represented as mean ± S.E.M from at least three independent experiments in triplicate. Statistical significance was determined by Student's unpaired t-test (p < 0.05 was considered statistically significant).
Time-resolved FRET
The experiments were conducted as described previously (McVey et al., 2001; Carrillo et al., 2003) . Briefly, HEK293 cells were transfected with cDNA encoding the human H 1 R-FLAG or H 1 R-c-myc or co-transfected with both constructs together. Time-resolved FRET was assessed in whole cells expressing the aforementioned receptors or in membrane homogenates from these cells. The final amount of sample per assay were 250 µg of protein in the case of cell membranes and 1.2-1.5 x 10 6 cells when using whole cells. Samples were incubated during 2 hours at room temperature in PBS (16 mM Na 2 HPO 4 , 5 mM NaH 2 PO 4 , 150 mM NaCl) containing 50% New Born Calf Serum (v/v), 
GPCR co-immunoprecipitation studies
Co-immunoprecipitation studies using FLAG and c-myc tagged forms of the human H 1 R were performed as in (McVey et al., 2001; Ramsay et al., 2002) , except that 30U/ml of endoglycosidase F were added to deglycosylate the receptor.
Results

Co-immunoprecipitation of human H 1 receptors
The human H 1 R was modified at the N terminus to include c-myc or FLAG epitope tags immediately after the N-terminal methionine. Following transient co-expression of both tagged forms of the receptor and immunoprecipitation with anti-FLAG antibodies, the samples were resolved by SDS-PAGE and immunoblotted to detect anti-c-myc immunoreactivity. Two bands of an apparent molecular mass of 48 and 100 kDa were observed, which would be consistent with the detection of both monomeric and dimeric forms of the H 1 receptor ( Figure 1A ). Other bands of higher molecular mass were also detected, which could be due to either the presence of higher order oligomers or receptor aggregation during the denaturalisation of the samples prior to SDS-PAGE. Furthermore, the anti-c-myc-immunoreactivity was detected neither when the c-myc and FLAG tagged forms of the receptor were expressed in separate cell populations nor when these two forms of the receptor were expressed independently and mixed before immunoprecipitation. Thus, the formation of aggregates during the solubilisation process can be ruled out. In order to confirm appropriate expression of both tagged forms of the receptor, samples of the cell lysates were also immunoblotted with anti-c-myc and anti-FLAG antibodies ( Figure 1B ).
Time-resolved Fluorescent Resonance Energy Transfer
Time-resolved FRET fluorescence results (665 nm emission after excitation at 320 nm) obtained with the different samples are shown in Figure 2 . In both cases, whole and cell membranes, there is a clear specific signal when comparing the results observed for cells when they were co-expressed (Maggio et al., 1993a; Maggio et al., 1993b; Monnot et al., 1996) . In these studies, co-expression of two radioligand-binding defective mutant receptors reconstituted a functional radioligand binding site, suggesting the molecular association of complementary transmembrane domains of two different defective mutant receptors. Several studies have identified critical amino acid residues in the H 1 R antagonist binding-pocket (Ohta et al., 1994; Moguilevsky et al., 1998; Wieland et al., 1999 19 performed on one, presumably independent population of H 1 receptors, there is no discrepancy in the number of ligand binding sites. Therefore, these data confirm our previous suggestion on the notion of distinct wild-type H 1 receptor subpopulations (Booth et al., 2002 ).
In conclusion, we demonstrate the existence of dimeric H 1 Rs, and in particular domainswapped H 1 R dimers. These domain swapped dimers form a subpopulation of H 1 Rs exhibiting a classical H 1 R pharmacological profile when profiled using diverse radioligands. The current results are in accord with previous findings on the binding of 
